NYSE
37.12USD
-0.01 (-0.03%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
3.5B
P/E
—
EPS
—
Beta
0.79
52W range
34.92-44.11
Day range
37.05–37.40
Open
37.12
Prev close
37.13
Volume
233.1K
Avg volume
308.7K
Dividend
3.41
IPO
1988-04-14
https://www.marketbeat.com/instant-alerts/equitable-q2-earnings-call-highlights-2026-08-08/ · 8/8/2026+0.80
https://seekingalpha.com/article/4926249-alliancebernstein-record-aum-in-q2-big-yield-and-steady-fundamentals · 7/28/2026+0.60
https://seekingalpha.com/article/4918712-alliancebernstein-undervalued-high-yield-asset-manager-with-durable-fee-based-income · 6/30/2026+0.80
https://seekingalpha.com/article/4914569-alliancebernstein-value-and-income-when-the-market-has-neither · 6/12/2026+0.80
https://www.globenewswire.com/news-release/2026/06/09/3309168/0/en/AB-Science-is-invited-to-present-at-the-2026-ENCALS-annual-meeting-the-survival-data-from-masitinib-clinical-program-in-ALS.html · 6/9/2026+0.80
https://www.prnewswire.com/news-releases/ab-announces-january-31-2026-assets-under-management-302685406.html · 2/11/2026+0.20
https://www.globenewswire.com/news-release/2025/12/22/3209429/0/en/AB-Science-patent-for-masitinib-in-the-treatment-of-sickle-cell-disease-formally-granted-in-the-US-with-a-protection-until-2040.html · 12/22/2025+1.00
https://www.globenewswire.com/news-release/2025/12/15/3205726/0/en/AB-Science-announces-a-new-publication-on-biorxiv-that-identifies-AB8939-as-a-promising-drug-candidate-for-treating-refractory-acute-myeloid-leukemia-and-potentially-other-cancers.html · 12/15/2025+0.80
https://www.zacks.com/stock/news/2799837/franklin-s-november-aum-edges-lower-despite-positive-markets?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_finance_sector-2799837 · 12/4/2025+0.00
https://www.zacks.com/stock/news/2799819/alliancebernstein-ab-moves-to-buy-rationale-behind-the-upgrade?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2799819 · 12/4/2025+0.80
https://www.defenseworld.net/2025/11/29/american-century-companies-inc-has-47-82-million-stake-in-alliancebernstein-holding-l-p-ab.html · 11/29/2025-0.30
https://www.zacks.com/stock/news/2776588/ab-or-cns-which-is-the-better-value-stock-right-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_3-2776588 · 10/24/2025+1.00
AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm provides its services to investment companies, pension and profit-sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations and other business entities. The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fixed-income securities, commodities, currencies, real estate-related assets and inflation-protected securities. The firm employs quantitative analysis along with long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies to make its investments. The firm obtains external research to complement its in-house research. The firm was formerly known as Alliance Capital Management Holding LP. AllianceBernstein Holding L.P. was founded in 1967 and is based in Nashville,Tennessee with additional offices in New York.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
